A single-institution experience of pneumonitis in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors.

被引：0
|
作者：
Masur, Jack
Ali, Soham
Fortune, Kathryn
Bueno, Juliana
Battey, Thomas
Mullapudi, Abhishek
Goudarzi, Ariaz
Patel, Hitesh
Sturek, Jeffrey
Devitt, Michael Edward
Skelton, William Paul
Dreicer, Robert
Viscuse, Paul Vincent
机构：
[1] Univ Virginia, Div Hematol Oncol, Charlottesville, VA USA
[2] Univ Virginia, Dept Internal Med, Charlottesville, VA USA
[3] Univ Virginia, Dept Radiol & Med Imaging, Charlottesville, VA USA
[4] Univ Virginia, Sch Med, Charlottesville, VA USA
[5] Univ Virginia, Div Pulm & Crit Care Med, Charlottesville, VA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 5_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.5_suppl.475
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Association of antibiotic therapy and treatment efficacy in patients with renal cell carcinoma receiving immune checkpoint inhibitors.
    Braun, Avery
    Deng, Mengying
    Handorf, Elizabeth A.
    Abbosh, Philip
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [42] Neopterin as a potential prognostic and predictive biomarker in metastatic renal cell carcinoma treated with immune checkpoint inhibitors
    Studentova, Hana
    Hola, Katerina
    Melichar, Bohuslav
    Spisarova, Martina
    EXPERT REVIEW OF ANTICANCER THERAPY, 2024, 24 (06) : 339 - 345
  • [43] Impact of renin-angiotensin system inhibitors on outcomes in patients with metastatic renal cell carcinoma treated with immune-checkpoint inhibitors
    Nuzzo, Pier Vitale
    Adib, Elio
    Weise, Nicole
    Curran, Catherine
    Stewart, Tyler
    Freeman, Dory
    Nassar, Amin H.
    Abou Alaiwi, Sarah
    Bakouny, Ziad
    McGregor, Bradley A.
    Choueiri, Toni K.
    Jain, Rakesh K.
    McKay, Rana R.
    Sonpavde, Guru
    CLINICAL GENITOURINARY CANCER, 2022, 20 (04) : 301 - 306
  • [44] Outcomes of patients with metastatic clear cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors.
    Shah, Amishi Yogesh
    Kotecha, Ritesh
    Lemke, Emily
    Chandramohan, Anuradha
    Chaim, Joshua
    Msaouel, Pavlos
    Xiao, Lianchun
    Gao, Jianjun
    Campbell, Matthew T.
    Zurita, Amado J.
    Wang, Jennifer
    Corn, Paul Gettys
    Jonasch, Eric
    Motzer, Robert J.
    Sharma, Padmanee
    Voss, Martin Henner
    Tannir, Nizar M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [45] Nivolumab (nivo) for patients (pts) with metastatic non-clear cell renal cell carcinoma (nccRCC): A single-institution experience.
    Chahoud, Jad
    Campbell, Matthew T.
    Gao, Jianjun
    Zurita, Amado J.
    Shah, Amishi Yogesh
    Msaouel, Pavlos
    Ross, Jeremy Aaron
    Xiao, Lianchun
    Jonasch, Eric
    Sharma, Padmanee
    Tannir, Nizar M.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [46] A real-world experience of immune checkpoint inhibitors (ICI) in metastatic renal cell carcinoma (mRCC)
    Elias, Roy
    Levonyak, Nicholas
    Christie, Alana
    Bowman, Isaac Alexander
    Kapur, Payal
    Hannan, Raquibul
    Hammers, Hans J.
    Brugarolas, James
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [47] Recurrent Pneumonitis in Patients with Melanoma Treated with Immune Checkpoint Inhibitors
    Asher, Nethanel
    Marom, Edith M.
    Ben-Betzalel, Guy
    Baruch, Erez Nissim
    Steinberg-Silman, Yael
    Schachter, Jacob
    Shapira-Frommer, Ronnie
    Markel, Gal
    ONCOLOGIST, 2019, 24 (05): : 640 - 647
  • [48] Immune Checkpoint Inhibitor-Associated Diabetes: A Single-Institution Experience
    Byun, David J.
    Braunstein, Rebecca
    Flynn, Jessica
    Zheng, Junting
    Lefkowitz, Robert A.
    Kanbour, Sarah
    Girotra, Monica
    DIABETES CARE, 2020, 43 (12) : 3106 - 3109
  • [49] Radical Nephrectomy After Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma
    Yanagisawa, Takafumi
    Schmidinger, Manuela
    Kawada, Tatsushi
    Bekku, Kensuke
    Kimura, Takahiro
    Shariat, Shahrokh F.
    EUROPEAN UROLOGY FOCUS, 2023, 9 (02): : 275 - 277
  • [50] Predictive biomarkers of response to immune checkpoint inhibitors in metastatic renal cell carcinoma
    Motoshima, Takanobu
    Miura, Yuji
    Amami, Toshiki
    Kitano, Shigeyasu
    Baba, Masaya
    Kamba, Tomomi
    CANCER RESEARCH, 2023, 83 (07)
12345